- Internship - Houston Methodist Hospital (2015-2016)
- Fellowship - Icahn School of Medicine at Mount Sinai (2018-2021), Hematology Oncology
- Residency - Houston Methodist Hospital (2015-2018), Internal Medicine
- Medical School - Baylor College of Medicine (2011-2015)
Qian Qin, M.D.
- Internal Medicine - Hematology/Oncology
- Bladder Cancer
- Kidney Cancer
New Patient Appointment Accepting Virtual Visits or 214-645-8300
Qian Qin, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in bladder, kidney, prostate, and testicular cancer.
Dr. Qin earned her medical degree at Baylor College of Medicine. She completed her residency in internal medicine at Houston Methodist Hospital and gained advanced training through a hematology and medical oncology fellowship at the Icahn School of Medicine at Mount Sinai.
Certified by the Board of Internal Medicine, she joined the UT Southwestern faculty in 2021.
Dr. Qin is a member of the American Medical Association and the American Society of Clinical Oncology. She has published numerous academic articles and delivered several presentations.
Education & Training
Professional Associations & Affiliations
- American Medical Association
- American Society of Clinical Oncology
- American Society of Hematology
Books & Publications
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms.
Qin Q, Xu Y, He T, Qin C, Xu J, Cell research 2012 Jan 22 1 90-106
Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma.
Qin Q, Nan X, Miller T, Fisher R, Teh B, Pandita S, Farach AM, Pingali SR, Pandita RK, Butler EB, Pandita TK, Iyer SP Radiation research 2018 Jun
Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy.
Parikh AB, Zhong X, Mellgard G, Qin Q, Patel VG, Wang B, Alerasool P, Garcia P, Leiter A, Gallagher EJ, Clinton S, Mortazavi A, Monk P, Folefac E, Yin M, Yang Y, Galsky M, Oh WK, Tsao CK, American journal of clinical oncology 2021 03 44 3 114-120
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.
Bhalla S, Bakouny Z, Schmidt AL, Labaki C, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, El Zarif T, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB, Lung cancer (Amsterdam, Netherlands) 2021 Jul 160 78-83
Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
Nan X, Qin Q, Gentille C, Ensor J, Leveque C, Pingali SR, Phan AT, Rice L, Iyer S Leukemia & lymphoma 2017 Jan 1-11
Urothelial carcinoma: the development of FGFR inhibitors in combination with immune checkpoint inhibitors.
Qin Q, Patel V, Galsky MD, Expert review of anticancer therapy 2020 06 20 6 503-512
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.
Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Christian K, Mascarenhas J, Dembitzer F, Moshier E, Tremblay D, Thrombosis research 2020 12 196 99-105
Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.
Schmidt AL, Bakouny Z, Bhalla S, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB, Cancer cell 2020 Dec 38 6 769-770
Characterizing Prostate-Specific Antigen Levels at Death in Patients with Metastatic Castration-Resistant Prostate Cancer: Are We Underutilizing Imaging?
Bikkasani K, Qin Q, Zhong X, Lin J, Galsky MD, Oh WK, Tsao CK, Clinical genitourinary cancer 2021 Apr
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
Tremblay D, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Feld J, Mascarenhas J, Troy K, Cromwell C, Dunn A, Oh WK, Naymagon L, Blood 2020 Jul 136 1 144-147
- Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms.
- Investigator-Initiated Clinical Trials in Genitourinary Oncology
- Industry- and Cooperative Group-Sponsored Trials in Genitourinary Oncology
- Novel Biomarkers, Therapeutics, and Therapeutic Combinations in Genitourinary Oncology
- Bladder Cancer
- Kidney Cancer
- Prostate Cancer
- Testicular Cancer
Results: 1 Locations
Genitourinary Cancer Clinicat Cancer Care Outpatient Building 6202 Harry Hines Blvd., 9th Floor
Dallas, Texas 75235 (214) 645-4673 Directions to Genitourinary Cancer Clinic Parking Info for Genitourinary Cancer Clinic